サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1375860

CBDコンシューマーヘルス市場の市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント予測、2023年～2030年

CBD Consumer Health Market Size, Share & Trends Analysis Report By Product (Medical OTC Products, Nutraceuticals), By Distribution Channels (Retail Pharmacies, Retail Stores, Online), By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 183 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.05円
CBDコンシューマーヘルス市場の市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月04日
発行: Grand View Research
ページ情報: 英文 183 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CBDコンシューマーヘルス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のCBDコンシューマーヘルス市場規模は2030年までに611億7,000万米ドルに達すると予測されています。

同市場は2023年から2030年にかけてCAGR 18.1％で成長すると予測されています。CBDの健康効果に関する認知度の高まりや、これらの製品を合法化する国の増加により、消費者向け健康製品としての採用が増加していることが、成長を促進する主な要因となっています。さらに、CBD製品に対する買い手の認識や態度の変化は、収益の成長を強化する重要な要因です。

製品タイプに基づくと、栄養補助食品は2019年に62.4%の収益シェアで市場を独占しました。CBDに関する認知度の上昇、栄養補助食品における化学ベースの成分からオーガニック成分へのユーザーの嗜好の変化、麻由来のCBDに対する政府の有利なイニシアチブは、成長を促進する主な要因です。この分野は、健康とウェルネス、スポーツ栄養、体重管理、その他の分野でのCBDベースの栄養補助食品の消費の増加により、予測期間中に最も速いCAGRを示すと予想されています。

流通チャネルに基づくと、小売薬局が2019年のCBDコンシューマーヘルス市場を独占しました。小売薬局経由で製品を販売する企業の増加が、このセグメントの成長を促進しています。しかし、オンラインストアセグメントは予測期間中に最も速い成長を示すと予測されています。これは、eコマースの浸透の増加、CBD入り製品に対する需要の高まり、CBDをオンラインで購入する消費者の嗜好、新興市場におけるこれらの製品の容易な入手可能性などに起因すると考えられます。

2019年の市場は北米が59.8%の収益シェアを占めました。消費者の間でCBDの医療効果に対する認識が高まっていることから、同地域ではオンライン販売や小売販売の売上が拡大しています。一方、欧州は、消費量の増加、認知度の向上、CBD製品に関する前向きな姿勢、同地域の主要企業による戦略的投資などにより、急成長地域となる見込みです。

CBDコンシューマーヘルス市場レポートハイライト

  • 栄養補助食品は、消費者の嗜好が化学由来成分からオーガニック成分やハーブ成分へと変化しているため、2022年の売上シェアは60％となり、市場を独占しました。
  • オンラインストアは、eコマースの浸透とオンラインで製品を提供する参入企業の増加により、予測期間中に最も急成長する流通チャネルセグメントになると予想されます。
  • 北米はCBDコンシューマーヘルス製品のCBDコンシューマーヘルス市場を独占し、2022年の売上高シェアは約70％でした。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CBDコンシューマーヘルス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • CBDコンシューマーヘルス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 CBDコンシューマーヘルス：製品タイプ、推定・動向分析

  • CBDコンシューマーヘルス市場：重要なポイント
  • CBDコンシューマーヘルス市場：動向と市場シェア分析、2022年および2030年
  • 医療用OTC製品
    • 医療用OTC製品市場推計・予測、2018～2030年
    • CBD鎮痛製品
    • CBD皮膚科製品
    • CBDメンタルヘルス製品
    • CBD睡眠補助製品
    • その他のOTC製品
  • 栄養補助食品
    • 栄養補助食品市場推計・予測、2018～2030年
    • CBDビタミンと栄養補助食品（VDS）
    • CBDスポーツ栄養
    • CBDの体重管理と健康

第5章 CBDコンシューマーヘルス：流通チャネル、推定・動向分析

  • CBDコンシューマーヘルス市場：重要なポイント
  • CBDコンシューマーヘルス市場：動向と市場シェア分析、2022年および2030年
  • 小売薬局
  • オンライン
  • 小売店

第6章 CBDコンシューマーヘルス市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別のCBDコンシューマーヘルス市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Elixinol Global Limited
    • ENDOCA
    • NuLeaf Naturals LLC
    • Kazmira
    • Charlotte's Web
    • Joy Organics
    • Lord Jones
    • Medical Marijuana Inc
    • CV Sciences Inc
    • Isodiol International Inc
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 3 North America cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 4 North America cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 6 U.S. cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 8 Canada cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Europe cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 10 Europe cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Europe cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 13 Germany cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 UK cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 15 UK cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16 France cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 17 France cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Italy cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 19 Italy cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Spain cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 21 Spain cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 Sweden cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 23 Sweden cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Norway cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 25 Norway cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Denmark cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 27 Denmark cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
  • Table 31 China cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 32 China cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Japan cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 34 Japan cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 India cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 36 India cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Australia cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 38 Australia cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Thailand cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 40 Thailand cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 South Korea cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 42 South Korea cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Latin America cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 44 Latin America cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Latin America cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 47 Brazil cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Mexico cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 49 Mexico cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Argentina cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 51 Argentina cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 56 South Africa cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 UAE cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 60 UAE cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Kuwait cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cannabidiol (CBD) consumer health: Market outlook
  • Fig. 9 Cannabidiol (CBD) consumer health: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cannabidiol (CBD) consumer health market driver impact
  • Fig. 15 Cannabidiol (CBD) consumer health market restraint impact
  • Fig. 16 Cannabidiol (CBD) consumer health market strategic initiatives analysis
  • Fig. 17 Cannabidiol (CBD) consumer health market: Product Type movement analysis
  • Fig. 18 Cannabidiol (CBD) consumer health market: Product Type outlook and key takeaways
  • Fig. 19 Medical OTC products market estimates and forecasts, 2018 - 2030
  • Fig. 20 Nutraceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 21 Cannabidiol (CBD) consumer health market: Distribution channel movement analysis
  • Fig. 22 Cannabidiol (CBD) consumer health market: Distribution channel outlook and key takeaways
  • Fig. 23 Retail pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 24 Online market estimates and forecasts, 2018 - 2030
  • Fig. 25 Retail stores market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global cannabidiol (CBD) consumer health market: Regional movement analysis
  • Fig. 27 Global cannabidiol (CBD) consumer health market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-762-9

CBD Consumer Health Market Growth & Trends:

The global CBD consumer health market size is anticipated to reach USD 61.17 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 18.1% from 2023 to 2030. The growing adoption of cannabidiol (CBD) as a consumer health product due to increasing awareness about the health benefits of CBD and rise in the number of countries legalizing these products are the key factors driving the growth. Furthermore, the changing buyer perception and attitude toward cannabidiol products is an important factor bolstering the revenue growth.

Based on product type, nutraceuticals dominated the market with a revenue share of 62.4% in 2019. Rising awareness regarding cannabidiol, changing user preferences from chemical-based ingredients to organic ingredients in dietary supplements, and favorable government initiatives for hemp-derived cannabidiol are the key factors driving the growth. The segment is anticipated to witness the fastest CAGR during the forecast period, owing to an increase in the consumption of CBD-based nutraceutical products in health and wellness, sports nutrition, weight management, and other fields.

Based on distribution channels, retail pharmacies dominated the market for cannabidiol consumer health in 2019. An increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment. However, the online stores segment is anticipated to witness fastest growth over the forecast period. This can be attributed to the increase in penetration of e-commerce, rising demand for CBD-infused products, preference of consumers for buying CBD online, and easy availability of these products in emerging markets.

North America dominated the market in 2019, with a revenue share of 59.8%. The growing awareness about the medical benefits of CBD among consumers has resulted in greater sales of online and retail sales in the region. On the other hand, Europe is expected to be the fastest-growing region, owing to an increase in consumption, rising awareness, positive attitudes regarding CBD products, and strategic investments by major companies in the region.

CBD Consumer Health Market Report Highlights:

  • Nutraceuticals dominated the market in 2022 with a revenue share of 60%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements
  • Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online
  • North America dominated the CBD consumer health market for cannabidiol consumer health products, with a revenue share of around 70% in 2022.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product Type
    • 1.1.2. Distribution channel
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Distribution channel outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cannabidiol (CBD) Consumer Health Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Cannabidiol (CBD) Consumer Health Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Cannabidiol (CBD) Consumer Health: Product Type Estimates & Trend Analysis

  • 4.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
  • 4.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Medical OTC Products
    • 4.3.1. Medical OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. CBD Analgesic Products
      • 4.3.2.1. CBD analgesic products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. CBD Dermatology Products
      • 4.3.3.1. CBD dermatology products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. CBD Mental Health Products
      • 4.3.4.1. CBD mental health products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. CBD Sleeping Aids Products
      • 4.3.5.1. CBD sleeping aids products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Other OTC Products
      • 4.3.6.1. Other OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Nutraceuticals
    • 4.4.1. Nutraceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. CBD Vitamins and Dietary Supplements (VDS)
      • 4.4.2.1. CBD vitamins and dietary supplements (VDS) market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. CBD Sports Nutrition
      • 4.4.3.1. CBD sports nutrition market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. CBD Weight Management and Wellbeing
      • 4.4.4.1. CBD weight management and wellbeing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cannabidiol (CBD) Consumer Health: Distribution Channel Estimates & Trend Analysis

  • 5.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
  • 5.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Retail Pharmacies
    • 5.3.1. Retail pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Online
    • 5.4.1. Online market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Retail Stores
    • 5.5.1. Retail stores market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cannabidiol (CBD) Consumer Health Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Cannabidiol (CBD) Consumer Health Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Elixinol Global Limited
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. ENDOCA
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. NuLeaf Naturals LLC
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Kazmira
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Charlotte's Web
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Joy Organics
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Lord Jones
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Medical Marijuana Inc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. CV Sciences Inc
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Isodiol International Inc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives